Foster & Motley Inc Amgen Inc Transaction History

Foster & Motley Inc

$1.86 Billion
Q3 2025

A detailed history of Foster & Motley Inc transactions in Amgen Inc stock. As of the latest transaction made, Foster & Motley Inc holds 33,589 shares of AMGN stock, worth $11.5 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

33,589

Previous 34,459 2.52%

Holding current value

$11.5 Million

Previous $9.62 Million 1.48%

% of portfolio

0.51%

Previous 0.56%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$271.18 - $309.22 $235,926 - $269,021	-870 Reduced 2.52%	33,589 $9.48 Million
Q2 2025 Jul 29, 2025	BUY	$262.28 - $309.85 $92,584 - $109,377	353 Added 1.04%	34,459 $9.62 Million
Q1 2025 May 08, 2025	SELL	$258.59 - $327.36 $200,665 - $254,031	-776 Reduced 2.22%	34,106 $10.6 Million
Q4 2024 Jan 23, 2025	SELL	$258.78 - $328.31 $91,349 - $115,893	-353 Reduced 1.0%	34,882 $9.09 Million
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $402,812 - $439,268	-1,302 Reduced 3.56%	35,235 $11.4 Million

Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $183,399 - $222,878	-698 Reduced 1.87%	36,537 $11.4 Million
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $77,972 - $94,122	-290 Reduced 0.77%	37,235 $10.6 Million
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $8,182 - $9,230	32 Added 0.09%	37,525 $10.8 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $15,086 - $18,730	69 Added 0.18%	37,493 $10.1 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $143,346 - $169,504	669 Added 1.82%	37,424 $8.31 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $629,502 - $767,257	2,788 Added 8.21%	36,755 $8.89 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $90,695 - $115,239	-396 Reduced 1.15%	33,967 $8.92 Million
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $68,460 - $77,210	-305 Reduced 0.88%	34,363 $7.75 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $201,640 - $224,390	-874 Reduced 2.46%	34,668 $8.44 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $235,057 - $260,035	-1,072 Reduced 2.93%	35,542 $8.6 Million
Q4 2021 Jan 25, 2022	SELL	$198.88 - $227.6 $301,104 - $344,586	-1,514 Reduced 3.97%	36,614 $8.24 Million
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $250,266 - $293,217	-1,179 Reduced 3.0%	38,128 $8.11 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $117,724 - $130,606	-504 Reduced 1.27%	39,307 $9.58 Million
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $257,859 - $300,493	-1,162 Reduced 2.84%	39,811 $9.91 Million
Q4 2020 Feb 01, 2021	SELL	$216.38 - $257.67 $180,460 - $214,896	-834 Reduced 1.99%	40,973 $9.42 Million
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $708,643 - $788,069	-3,020 Reduced 6.74%	41,807 $10.6 Million
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $466,238 - $572,138	-2,357 Reduced 5.0%	44,827 $10.6 Million
Q1 2020 Apr 21, 2020	BUY	$182.24 - $241.7 $63,784 - $84,595	350 Added 0.75%	47,184 $9.57 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $469,619 - $603,622	-2,482 Reduced 5.03%	46,834 $11.3 Million
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $54,148 - $64,880	311 Added 0.63%	49,316 $9.54 Million
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $38,341 - $44,944	230 Added 0.47%	49,005 $9.03 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $614,596 - $692,784	3,398 Added 7.49%	48,775 $9.27 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $16,056 - $18,742	90 Added 0.2%	45,377 $8.83 Million
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $314,622 - $354,695	-1,698 Reduced 3.61%	45,287 $9.39 Million
Q2 2018 Jul 24, 2018	SELL	$166.05 - $186.51 $15,442 - $17,345	-93 Reduced 0.2%	46,985 $8.67 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $2,710 - $3,168	-16 Reduced 0.03%	47,078 $8.03 Million
Q4 2017 Jan 22, 2018	BUY	$168.79 - $188.59 $96,885 - $108,250	574 Added 1.23%	47,094 $8.19 Million
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $7.78 Million - $8.89 Million	46,520	46,520 $8.67 Million

Others Institutions Holding AMGN

# of Institutions

3,273

Shares Held

428M

Call Options Held

6.11M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Account

Foster & Motley Inc Amgen Inc Transaction History